Rtw Biotech Regulatory News (RTW)

LEI: 549300Q7EXQQH6KF7Z84

03 October 2023

RTW Biotech Opportunities Ltd (the "Company")

Director Declaration

In accordance with Listing Rule 9.6.14(2), the Company advises that Paul Le Page, a non-executive director of the Company, has been appointed as an independent non-executive director of NextEnergy Solar Fund Limited, a LSE listed FTSE 250 company, with effect from 03 October 2023. In addition, Paul Le Page has recently resigned from Bluefield Solar Investment Fund Limited, an LSE listed FTSE 250 company.

Paul's role at NextEnergy Solar Fund Limited is not expected to impact his ability to allocate sufficient time to the Company to discharge his responsibilities effectively.

For Further Information:

 

About RTW Biotech Opportunities Ltd:

RTW Biotech Opportunities Ltd (LSE: RTW & RTWG) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Biotech Opportunities Ltd invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives. RTW Biotech Opportunities Ltd is managed by RTW Investments, LP, a leading healthcare-focused entrepreneurial investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies.

Visit the website at www.rtwfunds.com/rtw-biotech-opportunities-ltd for more information.